Blocking elevated p38 MAPK restores efferocytosis and inflammatory resolution in the elderly

Area of Science:

• Immunology
• Dermatology
• Aging Research

Background:

• Innate immune responses change with age, but mechanisms in humans are unclear.
• Inflammation resolution is critical for tissue homeostasis and preventing chronic disease.

Purpose of the Study:

• To investigate age-related differences in the resolution of acute inflammation in human skin.
• To identify molecular mechanisms underlying impaired inflammation resolution in elderly individuals.
• To evaluate the therapeutic potential of targeting identified pathways.

Main Methods:

• Utilized a human dermal model of acute inflammation to compare young and elderly individuals.
• Assessed macrophage efferocytosis and expression of T cell immunoglobulin mucin receptor-4 (TIM-4).
• Investigated the role of p38 mitogen-activated protein kinase (MAPK) in regulating TIM-4 and efferocytosis.

Main Results:

• Inflammatory onset was similar, but resolution was impaired in elderly individuals.
• Reduced TIM-4 expression on macrophages in the elderly impaired efferocytosis (clearance of apoptotic cells).
• Elevated macrophage p38 MAPK activity in the elderly caused reduced TIM-4.
• Oral p38 inhibitor administration restored TIM-4, efferocytosis, and macrophage resolution phenotype in the elderly.

Conclusions:

• Aging impairs the resolution of inflammation in humans through reduced TIM-4 expression mediated by p38 MAPK.
• Targeting p38 MAPK can reverse this age-related resolution defect, rejuvenating the immune response.
• This study identifies a novel, targetable mechanism for treating chronic inflammatory diseases associated with aging.